Dallas, Texas 09/04/2013 (Financialstrend) – It was earlier announced by Opko Health Inc. (NYSE:OPK) that the company’s stock was approved to be listed on the Tel Aviv Stock Exchange with the ticker symbol OPK and this had taken effect from August 21, 2013. This proves that the stock would be listed on the two stock exchanges, namely the NYSE exchange of the United States and the TASE exchange of Israel. Further, the company’s stock would also prove effective to join the Israel’s top trading companies as part of the TA-25 Index.
The Chairman and Chief Executive Officer of Opko Health Inc. (NYSE:OPK), Dr. Phillip Frost had commented that this move to get listed in the Israel’s Tel Aviv Stock Exchange would prove effective to increase the exposure of the company to the investment community of the country and would also provide for the expansion of interest in the stock among the large and sophisticated institutional investors of the country. OPKO is primarily engaged in the development and commercialization of wide range of medical solutions for the diagnosis, treatment and prevention of various disorders and the solutions developed by the company include molecular diagnostic tests, pharmaceuticals, vaccines and point of care tests.
Shares of Opko Health Inc. (NYSE:OPK) dipped on Tuesday to close at $9.19 per share, a decrease of 0.54% over the previous close. The stock prices for the day traded in the range of $8.85 to $9.27 per share. For the past 52 weeks, the stock had presented low price at $4.05 and high price at $10.00 per share. The stock managed to pull in around 8.37 million trades on Tuesday, while the average level for the past 30 days of trading is at 2.59 million shares per day. There are presently 336.81 million outstanding shares for the company and the institutional ownership is at 16%.